Obturator and Femoral Nerve Block in Patients With Hip Fracture

May 13, 2016 updated by: University of Aarhus

Analgesic Effect of an Obturator Nerve Block Combined With a Femoral Nerve Block Compared With Femoral Nerve Block Alone in Patients With Hip Fracture

A higher number than expected of patients with hip fracture have only insufficient analgesic effect of a femoral nerve block, which is the nerve block commonly used for this group of patients. One of the possible causes of this failure to provide analgesia from a single nerve block could be the that other nerves are involved in transmitting the pain signal. One of the nerves that is believed to give off branches to the hip is the obturator nerve.

With ultrasound it is possible to make a selective proximal nerve block of the obturator nerve.

The aim of this trial is to test the analgesic effect of a femoral nerve block i combination with an obturator nerve block compared to femoral nerve block alone in a randomized and placebo controlled design.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

A higher number than expected of all patients with hip fracture have only insufficient analgesic effect of a femoral nerve block. One of the possible causes of this failure to provide analgesia from a single nerve block could be the that other nerves are involved in transmitting the pain signal. One of the nerves that is believed to give off branches to the hip is the obturator nerve. Earlier it was believed that the so called '3-in-1-block' or the iliac fascia compartment block would anesthetize also the obturator nerve, and these two nerve blocks have been uses extensively in the emergency ward for preoperative analgesia. Today that is not believed to be true and consequently is the part of the obturator nerve in patients with hip fracture unknown.

With ultrasound it is possible to make a selective proximal nerve block of the obturator nerve before it branches into an anterior and a posterior branch. A selective nerve block of the obturator nerve to access its effect in patients with hip fracture has to our knowledge never been done.

The aim of this trial is to test the analgesic effect of a femoral nerve block i combination with an obturator nerve block compared to femoral nerve block alone in a randomized and placebo controlled design.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical suspicion of hip fracture
  • Age ≥ 55 years
  • Mentally capable of comprehending and using verbal pain score
  • Mentally capable of differentiating between pain from the fractured hip and pain from other locations
  • Mentally capable of understanding the given information
  • Arrival in the emergency room at times when one of the doctors who do the nerve blocks for this investigation are on call
  • Verbal numeric pain scale score (NRS 0-10) > 5 with a dynamic test OR NRS > 3 at rest
  • Patients informed consent

Exclusion Criteria:

  • Hip fracture not confirmed by x-ray
  • Weight < 40 kg
  • Patient has previously been included in this trial
  • If the patient wishes to be excluded
  • Allergy to local anesthetics or adrenocortical hormone
  • Visible infection in the area of the point of needle injection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bupivacaine
Obturator nerve block
Obturator nerve block
Other Names:
  • Active nerve block
Placebo Comparator: Saline
Saline is injected as a placebo
Obturator nerve block with saline(placebo)
Other Names:
  • Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of successful analgesia, measured with numeric rating scale(NRS) 0-10 with 0=no pain and 10=worst pain. Successful analgesia = NRS<4 at rest and NRS <6 with passive movement of the fractured leg.
Time Frame: 30 minutes
Success rate of successful analgesia compared between the groups
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Median pain score (NRS 0-10)
Time Frame: 30 minutes
Median pain score 30 minutes after the nerve blocks compared between the groups
30 minutes
Median change in pain score (NRS 0-10)
Time Frame: 30 minutes
Median change in pain score 30 minutes after the nerve blocks compared between the groups
30 minutes
Course in pain reduction
Time Frame: 30 minutes
Course in pain reduction during the 30 minutes after the nerve blocks
30 minutes
Time to sufficient analgesia
Time Frame: 30 minutes
Time from ended injection until sufficient analgesia
30 minutes
Frequency of anesthesia in the skin area of the saphenous nerve
Time Frame: 30 minutes
Frequency of anesthesia in the skin area innervated by the saphenous nerve
30 minutes
Frequency of anesthesia in the skin area of the anterior cutaneous branches of the femoral nerve
Time Frame: 30 minutes
Frequency of anesthesia in the skin area of the anterior cutaneous branches of the femoral nerve
30 minutes
Localization of the worst pain before block
Time Frame: 0 minutes
Localization of the worst pain before any nerve blocks
0 minutes
Localization of the worst pain after block
Time Frame: 30 minutes
Localization of the worst pain 30 minutes after the nerve blocks
30 minutes
Discomfort during nerve block procedures (score 0-10, 0=no discomfort)
Time Frame: 5 minutes
Discomfort during the nerve block procedures compared between procedures
5 minutes
Satisfaction (0-10, 0= very unsatisfactory)
Time Frame: 30 minutes
Patient satisfaction with the pain treatment
30 minutes
Frequency of ultrasound visualization of femoral nerve
Time Frame: 5 minutes
Frequency of patients with possible ultrasound visualization af the femoral nerve
5 minutes
Frequency of ultrasound visualization of obturator injection site
Time Frame: 5 minutes
Frequency of patients with possible ultrasound visualization of the obturator nerve block injection site
5 minutes
Time spend on femoral nerve block
Time Frame: 5 minutes
Time spend on conducting the femoral nerve block
5 minutes
Time spend on obturator nerve block
Time Frame: 5 minutes
Time spend on conducting the obturator nerve block
5 minutes
Total morphine equivalent dose of opioid from the time of nerve block to operation
Time Frame: Approximately 24 hours in average
Total morphine equivalent dose of opioid from the time of nerve block until the time of operation
Approximately 24 hours in average
Total morphine equivalent dose of opioid/time from the time of nerve block to operation
Time Frame: Approximately 24 hours in average
Total morphine equivalent dose of opioid/time from the time of nerve block until the time of operation
Approximately 24 hours in average
Total morphine equivalent dose of opioid in the first 10 hours after nerve block
Time Frame: 10 hours
Total morphine equivalent dose of opioid given in the first 10 hours after nerve block
10 hours
Total morphine equivalent dose of opioid/time in the first 10 hours after nerve block
Time Frame: 10 hours
Total morphine equivalent dose of opioid/time given in the first 10 hours after nerve block
10 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Thomas F. Bendtsen, Ph.d., Aarhus University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Anticipated)

April 1, 2017

Study Completion (Anticipated)

April 1, 2017

Study Registration Dates

First Submitted

August 27, 2015

First Submitted That Met QC Criteria

September 1, 2015

First Posted (Estimate)

September 4, 2015

Study Record Updates

Last Update Posted (Estimate)

May 16, 2016

Last Update Submitted That Met QC Criteria

May 13, 2016

Last Verified

May 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Bupivacaine

Subscribe